National Comprehensive Cancer Network

Home | About NCCN | Find a Member Institution | Login/Register | Contact Us

NCCN 19^th Annual Conference: Advancing the Standard of Cancer Care™

NCCN Annual Congress: Hematologic Malignancies™

2013 Sponsor & Exhibitor Prospectus

2013 Advertising Rate Card

NCCN Academy for Excellence & Leadership in Oncology™

NCCN Academy for Excellence and Leadership in Oncology™

License NCCN Academy Video Modules!

Customize your own NCCN Academy Curriculum

About NCCN Academy

NCCN Oncology Policy Program

Comparative Effectiveness in Cancer Care

Recommendations for REMS Stakeholders

NCCN Patient Advocacy Summit

Off-Label Drug Use and Compendia

Molecular Testing – Effectiveness, Efficiency, and Reimbursement

NCCN Patient Advocacy Summit: Ensuring Optimal Care for Patients

Equity in Cancer Care: Pathways, Protocols, and Guidelines

Data Needs in Oncology – Clinical, Regulatory, Coverage, and Policy Issues

Patient Advocacy: Patient Perspectives Across the Cancer Care Continuum

Evolving Policy Issues in Oncology – Revisiting Biosimilars and Molecular Testing

Measuring Quality in Oncology – Challenges and Opportunities

NCCN Online CME/CE

Interactive CME

Supporter Opportunities

Educational Events & Programs

NCCN 5^th Annual Congress: Hematologic Malignancies™

Agenda

Highlights include*

Friday, October 8, 2010

Registration, Breakfast, and Exhibits
7:15 – 8:30 AM

Welcome
8:30 – 8:40 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Plasma Cell Neoplasms
Evolving Strategies for Treating Myeloma
8:40 – 9:25 AM
Asher Chanan-Khan, MD
Roswell Park Cancer Institute

Diagnosis and Management of Waldenström’s Macroglobulinemia
9:30 – 10:15 AM
Cristina Gasparetto, MD
Duke Cancer Institute

Break and Exhibits
10:15 – 10:40 AM

Optimizing Bone Health in Patients with Myeloma
10:40 – 11:25 AM
Adam D. Cohen, MD
Fox Chase Cancer Center

Chronic Myelogenous Leukemia (CML)
Evolving Treatment Strategies in CML
11:30 AM – 12:15 PM
Susan O’Brien, MD
The University of Texas MD Anderson Cancer Center

Lunch and Exhibits
12:15 – 1:15 PM

Lymphomas

Adult T-Cell Leukemia and Lymphoma (ATLL)
1:15 – 2:00 PM
Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center

Hodgkin Lymphoma
2:05 – 2:50 PM
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Break and Exhibits
2:50 – 3:10 PM

Emerging Treatments for T-Cell Lymphoma
3:10 – 3:55 PM
Myron S. Czuczman, MD
Roswell Park Cancer Institute

Hepatitis B Viral Reactivation in Patients with Hematologic Malignancies
4:00 – 4:45 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Saturday, October 9, 2010

Registration, Breakfast, and Exhibits
7:15 – 8:00 AM

Welcome
8:00 – 8:05 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Practice Issues in Hematologic Oncology
Using Informatics Tools to Guide Therapy in Hematologic Malignancies
8:05 – 8:50 AM
Ephraim P. Hochberg, MD
Massachusetts General Hospital Cancer Center

Supportive Care
New Directions in the Prevention and Management of VTE
8:55 – 9:40 AM
Michael B. Streiff, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Prevention of Infections in Patients with Hematologic Malignancies
9:45 – 10:30 AM
John N. Greene, MD
Moffitt Cancer Center

Break and Exhibits
10:30 – 10:50 AM

Myeloid Growth Factors for the Management of Febrile Neutropenia
10:50 – 11:35 AM
Gary H. Lyman, MD
Duke Cancer Institute

Management of Disease-Specific Complications in CLL
11:40 AM – 12:25 PM
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

Subject to change as the agenda is finalized.